Missouri Judge Approves Bayer’s $7.25 Billion Roundup Settlement

A Missouri judge on Friday approved Bayer’s $7.25 billion settlement to resolve thousands of claims that its Roundup weed killer causes cancer, potentially ending nearly a decade of litigation over the herbicide.

St. Louis Circuit Judge Timothy Boyer called the average individual payouts “fair and adequate” and the total amount “among the largest in the history of mass tort personal-injury class action settlements.” The agreement includes $600 million for attorneys’ fees and covers both current claimants and those diagnosed with non-Hodgkin lymphoma in the future.

The amount of money paid out to individuals would vary.

The approval comes five months after the U.S. Supreme Court overturned a $1.25 million jury award for a Missouri man who blamed Roundup for his cancer. In a 7-2 decision, the court ruled that federal pesticide law bars failure-to-warn claims under state law, undercutting a central pillar of the lawsuits.

Standard award levels range from $10,000 to $165,000, though final payments can fall 20 percent above or below the applicable tier average. Agricultural, industrial or turf workers with lengthy exposure could receive an average of $165,000 if diagnosed with an aggressive form of the illness before age 60, while those diagnosed at 78 or older would average $10,000.

File image: Bottles of Monsanto's Roundup are seen for sale June 19, 2018 at a retail store in Glendale, California
Photo: Newsweek

A separate quick-pay route offers qualifying residential claimants between $6,000 and $14,500. Medical or governmental liens may reduce the amount reaching claimants.

Objectors argued the proposed awards were too small compared with amounts received through previous settlements.

The decision could be appealed, which would pause further payments into the settlement fund.

Judge Approves $7 Billion Roundup Settlement; 6.8-Magnitude Quake Shakes Peru — Frontion News

The company previously set aside $16 billion to cover legal costs and settled much of the litigation for $10.9 billion in 2020, but failed to win court approval for a $1.25 billion future-claims settlement at that time.

Bayer acquired Monsanto, Roundup’s maker, for $63 billion in 2018. Since then, its share price has fallen 46%. The World Health Organization’s International Agency for Research on Cancer classified glyphosate, Roundup’s active ingredient, as “probably carcinogenic” in 2015, while the U.S. Environmental Protection Agency has determined it is not likely to cause cancer in humans when used as directed.

About 200 lawsuits remain pending in federal court, which the company says are covered by strong defenses following the Supreme Court ruling. Roundup has been used on weeds for over 50 years. Missouri-based Monsanto debuted Roundup weed killer in 1974 with the chemical glyphosate as its active ingredient.

The lawsuits have produced mixed results. Only a couple dozen cases have gone to jurors, some siding with Bayer and others with plaintiffs. In one case, a Georgia jury awarded plaintiffs $2.1 billion. Attorneys disagree on whether the settlement is fair.

Missouri Judge Approves Bayer's $7.25 Billion Roundup Settlement
Photo: New York Post

As a result, Bayer has removed glyphosate from its new versions of Roundup sold for residential markets. The settlement excludes some lawsuits that remain pending in federal court.

Quick-pay awards receive priority.

Photo of author

Health Desk

Health Desk at Archyde.

UN States Agree to Elaborate Instrument on Killer Robots Over Two Years